Results 101 to 110 of about 3,355,558 (275)

Oral side effects of nicotine replacement therapy - A Network meta-analysis of randomized controlled trials

Oral side effects are a common adverse effect associated with nicotine replacement therapy.There are various forms of replacement therapy including gels, chewing gums and patches.
Kannan Sridharan, Muneera Alsobaiei, Gowri Sivaramakrishnan   +2 more
core   +3 more sources

The impact of the 2006 Scottish smoke-free legislation on sales of nicotine replacement therapy

, 2008
This study used over-the-counter (OTC) sales of nicotine replacement therapy (NRT) to investigate the impact of the introduction of smoke-free legislation in Scotland in March 2006 on smoking cessation behaviour.
Lewis, Sarah A, McNeill, Ann, Haw, Sally, Haw, Sally J, Lewis, Sarah, McNeill, Ann; id_orcid   +5 more
core   +1 more source

How the sales of oral nicotine pouches correlate with prices and respond to taxes on cigarettes and e‐cigarettes

Addiction, EarlyView.
Abstract Background and aims Oral nicotine pouches (ONPs) have seen a dramatic rise in sales since their introduction to the US market in 2016. We aimed to define the relationship between ONP prices and sales (e.g. price elasticity of demand) and determine how taxes on cigarettes and e‐cigarettes (ECs) impact ONP sales.
Yanyun He, Zezhong Zhang, Brittney Keller‐Hamilton, Megan E. Roberts, Darren Mays, Theodore L. Wagener, Micah L. Berman, Ce Shang   +7 more
wiley   +1 more source

Nicotine-replacement therapy: A proven treatment for smoking cessation

South African Family Practice, 2010
Smoking is a major cause of cardiovascular diseases, respiratory diseases and cancer. Despite the high prevalence of smokers worldwide, smokers are often neglected and not offered effective assistance with quitting their habits. In order to overcome this
Noorzurani Md Haris Robson
doaj   +1 more source

E-cigarettes helped more smokers quit than nicotine replacement therapy

The studyHajek P, Phillips-Waller A, Przulj D, et al. A randomised trial of e-cigarettes versus nicotine-replacement therapy. N Engl J Med 2019;380:629-37.This trial was funded by the NIHR Health Technology Assessment Programme (12/167/135) and by Cancer
Davidson, Peter, Cook, Rob, Martin, Rosie   +2 more
core   +1 more source

Calvarial Bone Channels and a Putative Craniomaxillary–Brain Interface in Central Nervous System Immunity

Med Research, EarlyView.
Ziwen Sheng, Yulong Zhang, Hao Wang, Wenyu Zhen, Youming Zhu, Haitao Wang, Hengguo Zhang   +6 more
wiley   +1 more source

Has Australia lost control of its tobacco and nicotine markets?

Addiction, EarlyView.
Abstract Background Australia has adopted two policies that the World Health Organization (WHO) recommends as best practice for tobacco control: it has steeply increased tobacco taxes since 2010 and only allowed access to nicotine vapes for medical use.
Ron Borland, James Martin, Edward Jegasothy, Ben Youdan, Wayne Hall   +4 more
wiley   +1 more source

Prevalence and risk perceptions of nicotine pouch use: A systematic review of population‐based studies

Addiction, EarlyView.
Abstract Background and Aims Oral nicotine pouches (NPs) are a new class of non‐combustible nicotine products that have gained rapid popularity. Despite rising sales and marketing, evidence of their prevalence and risk perceptions remains limited. This systematic review aimed to synthesize the available global evidence on the prevalence and patterns of
Salma Mahmoodianfard, Spencer Shahen, Javad Heshmati, Emma Bates, Evyanne Quirouette, Terefe Gelibo, Sarah Visintini, Hassan Mir   +7 more
wiley   +1 more source

Factors associated with smoking cessation in early and late pregnancy in the smoking, nicotine, and pregnancy trial: a trial of nicotine replacement therapy [PDF]

, 2014
Introduction: Previous studies have found partners’ smoking status, multiparity, and nicotine dependence to be associated with smoking cessation in pregnancy.
Leonardi-Bee, Jo, Vaz, LR, Grainge, Matthew, Leonardi-Bee, J, Cooper, S, Grainge, M, Cooper, Sue, Coleman, T, Vaz, Luis R., Aveyard, Paul, Coleman, Tim   +10 more
core   +1 more source

Beyond abstinence: Redefining success in cannabis use disorder treatment

Addiction, EarlyView.
Abstract Background Over two decades of pharmacotherapy research has yet to yield a consistently effective medication for cannabis use disorder (CUD), in part because clinical trials have frequently prioritized abstinence as a primary or key endpoint.
Tobias B. Atkin, Frances R. Levin, John Mariani, Christina A. Brezing   +3 more
wiley   +1 more source